12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock rose 42.9% to $2.3 during Monday’s pre-market session. The market value of their outstanding…
Despite Trial Failure, Satsuma Pharma Says Its Migraine Candidate Has Potential For Approval
Satsuma Pharmaceuticals Inc (NASDAQ: STSA) provided an update on its STS101 development program and corporate update.
Satsuma Pharmaceuticals Says Analysis Of Results From Recently-Completed Summit Phase 3 Efficacy Trial Of Sts101 For The Acute Treatment Of Migraine Shows Differentiating Robust, Sustained Antimigraine Effects On Clinically Important Secondary Endpoint…
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
Further analysis of results from recently-completed SUMMIT Phase 3 efficacy trial of STS101 for the acute treatment of migraine shows
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
Expert Ratings for Satsuma Pharmaceuticals
Over the past 3 months, 6 analysts have published their opinion on Satsuma Pharmaceuticals (NASDAQ:STSA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
HC Wainwright & Co. Maintains Buy on Satsuma Pharmaceuticals, Lowers Price Target to $3
HC Wainwright & Co. analyst Oren Livnat maintains Satsuma Pharmaceuticals (NASDAQ:STSA) with a Buy and lowers the price target from $18 to $3.
SVB Leerink Downgrades Satsuma Pharmaceuticals to Market Perform, Lowers Price Target to $1
SVB Leerink analyst Marc Goodman downgrades Satsuma Pharmaceuticals (NASDAQ:STSA) from Outperform to Market Perform and lowers the price target from $15 to $1.
Dow Surges 150 Points; Crude Oil Falls Sharply
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.